Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|12|992-1001

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.12, 2015-12, pp. : 992-1001

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors associated with sustained virological response in 24‐week telaprevir‐based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 4, 2015-04 ,pp. : 387-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative safety study on severe anemia by simeprevir versus telaprevir‐based triple therapy for chronic hepatitis C

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 8, 2015-08 ,pp. : 1309-1316

John Wiley & Sons Inc

Access to resources Recommend Favorite

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 3, 2015-03 ,pp. : 254-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multicenter prospective study to optimize the efficacy of triple therapy with telaprevir in patients with genotype 1b hepatitis C virus infection according to an algorithm based on the drug Adherence, IL‐28B Gene Allele and Viral Response Trial (AG

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 11, 2015-11 ,pp. : 1091-1099

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of telaprevir‐based therapy for difficult‐to‐treat patients with genotype 2 chronic hepatitis C in Japan

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 7, 2015-07 ,pp. : 745-754

John Wiley & Sons Inc

Access to resources Recommend Favorite